XML 57 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Related Parties Transactions (Tables)
 9 Months Ended
Sep. 30, 2019
Related Party Transactions [Abstract]  
Schedule of related party transactions

Name of entity or Individual   Relationship with the Company and its subsidiaries
BioFirst Corporation (the “BioFirst”)   Entity controlled by controlling beneficiary shareholder of Yuangene
BioFirst (Australia) Pty Ltd. (the “BioFirst (Australia)”)   100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
Rgene Corporation (the “Rgene”)   Shareholder of the Company; entity controlled by controlling beneficiary shareholder of Yuangene
Yuangene Corporation (the “Yuangene”)   Controlling beneficiary shareholder of the Company
AsiaGene Corporation (the “AsiaGene”)   Shareholder; entity controlled by controlling beneficiary shareholder of Yuangene
Eugene Jiang   Former President and Chairman
Keypoint Technology Ltd. (the “Keypoint’)   The Chairman of Keypoint is Eugene Jiang’s mother.
Lion Arts Promotion Inc. (the “Lion Arts”)   Shareholder of the Company
Yoshinobu Odaira (the “Odaira”)   Director of the Company
GenePharm Inc. (the “GenePharm”)   Mr. George Lee, the Director and Chairman of Biokey, is the Chairman of GenePharm.
Euro-Asia Investment & Finance Corp Ltd. (the “Euro-Asia”)   Shareholder of the Company
LBG USA, Inc. (the “LBG USA”)   100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
LionGene Corporation (the “LionGene”)   Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
Kimho Consultants Co., Ltd. (the “Kimho”)   Shareholder of the Company
Mr. Tsung-Shann Jiang, Ms. Shu-Ling Jiang, Mr. Chang-Jen Jiang, Ms. Mei-Ling Jiang, and Mr. Eugene Jiang (collectively the “Jiangs”)  

Mr. Tsung-Shann Jiang, the controlling beneficiary shareholder of the Company and Rgene, the Chairman and CEO of the BioLite Holding Inc. and BioLite Inc. and the President and a member of board of directors of BioFirst. 

 

Ms. Shu-Ling Jiang, Mr. Tsung-Shann Jiang’s wife, is the Chairman of Keypoint, LION, and BioFirst; and a member of board of directors of BioLite Inc. 

 

Mr. Eugene Jiang is Mr. and Ms. Jiang’s son. Mr. Eugene Jiang is the chairman, and majority shareholder of the Company and a member of board of directors of BioLite Inc. 

 

Mr. Chang-Jen Jiang is Mr. Tsung-Shann Jiang’s sibling and the director of the Company. 

 

Ms. Mei-Ling Jiang is Ms. Shu-Ling Jiang’s sibling.
Schedule of accounts receivable related parties

   September 30,   December 31, 
   2019   2018 
GenePharm Inc.  $142,215   $    - 
Total  $142,215   $- 
Schedule of amount due from related parties

   September 30,   December 31, 
   2019   2018 
Rgene  $34,220   $19,477 
AsiaGene   3,353    - 
BioFirst   132,650    - 
BioFirst (Australia)   40,000    40,000 
BioHopeKing Corporation   111,780    - 
LBG USA   675    - 
Total  $322,678   $59,477 
Schedule of amount due to related party

   September 30,   December  31, 
   2019   2018 
Lion Arts Promotion Inc  $-   $65,495 
LionGene Corporation   -    458,348 
BioFirst Corporation   142,688    6,428,643 
AsiaGene   24,017    160,000 
YuanGene   9,205    92,690 
The Jiangs   4,735    539,920 
Kimho   7,500    - 
Due to shareholders   188,315    - 
Total  $376,460   $7,745,096